No Data
No Data
Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) 40% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
To the annoyance of some shareholders, Werewolf Therapeutics, Inc. (NASDAQ:HOWL) shares are down a considerable 40% in the last month, which continues a horrid run for the company. The last month h
Express News | JMP Securities Reiterates Market Outperform on Werewolf Therapeutics, Maintains $12 Price Target
12 Health Care Stocks Moving In Monday's Intraday Session
GainersStructure Therapeutics (NASDAQ:GPCR) stock moved upwards by 71.0% to $58.47 during Monday's regular session. The market value of their outstanding shares is at $2.7 billion. Concord Medical Ser
Analysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL), Eli Lilly & Co (LLY) and Envista Holdings (NVST)
Express News | Werewolf Therapeutics: Wtx-124 Shown to Be Clinically Active and Generally Well-Tolerated in Patients
Express News | Werewolf Therapeutics to Present Data From Ongoing Phase 1/1B Clinical Trial of Wtx-124 as Monotherapy and in Combination With Pembrolizumab in Solid Tumors
No Data